The Innovative Medicines Initiative project published a series of recommendations for how the regulatory process in the EU for approving cell and gene therapies could be sped up

The news means we are one step closer to treating adult patients with complicated intra-abdominal and urinary tract infections and hospital-acquired pneumonias caused by Gram-negative bacteria

The findings, published in Nature Aging, illustrate the benefit of large datasets such as the EPND database to find important patterns in biological data.

Findings from Innovative Medicines Initiative project BigData@Heart underscore the importance of accounting for sex-based differences in medical research.

A new non-profit company is delivering fully characterised, lab-based paediatric tumour models for testing potential cancer therapies, thanks to the IMI ITCC-P4 project’s results.

Results from IMI project COMBACTE-CARE show that – if approved – a new combination of drugs could help in the fight against some of the most dangerous drug-resistant bacteria.

The standards were developed by a multi-stakeholder group including people living with asthma as well as doctors, pharmaceutical companies, and health policymakers.

The European Platform for Neurodegenerative Diseases has created a Cohort Catalogue to help to accelerate the hunt for biological markers of neurodegenerative diseases like Alzheimer's and Parkinson's diseases.

Using smartphones to self-report and monitor thinking difficulties could help to monitor and manage depression, according to new research from IMI project RADAR-CNS.

Data gathered during Innovative Medicines Initiative project DIRECT helped scientists to pinpoint genetic variants associated with a good response to diabetes drugs called GLP-1 agonists.